$14.32-0.04 (-0.28%)
Brookdale Senior Living Inc.
Brookdale Senior Living Inc. in the Healthcare sector is trading at $14.32. The stock is currently 16% below its 52-week high of $17.09, remaining 30.4% above its 200-day moving average. Technical signals show neutral RSI of 62 and bullish MACD crossover, explaining why BKD maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Indep...
The latest analyst update on Brookdale Senior Living centers on a higher fair value estimate, with the modeled price target moving from US$13.13 to US$19.10 and one firm lifting its target to US$19.50 after the Q4 update. Bullish analysts point to reaffirmed guidance, steady adjusted EBITDA assumptions, and a cluster of upward revisions as justification for assigning richer valuation targets, while more cautious voices highlight execution and guidance risk. As you read on, you will see how...
Here is how Brookdale Senior Living (BKD) and Coherus Oncology (CHRS) have performed compared to their sector so far this year.
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
BKD's Q1'26 occupancy climbs to 82.1%, marking a fourth straight quarter of year-over-year gains despite a slight dip from Q4'25.
Brookdale Senior Living Inc. recently completed a refinancing through KeyBank’s Freddie Mac program, raising US$185 million on seven communities to repay US$191 million of mortgage debt that was due in March 2027, and pushing those maturities out to April 2033 at a fixed 5.38% interest rate with two years of interest-only payments. This refinancing eases Brookdale’s near-term debt burden, aligns maturities with longer-term operational goals, and signals lenders’ continued confidence in the...